{"DataElement":{"publicId":"62596","version":"4","preferredName":"Anticoagulant Agent Administered Ind-3","preferredDefinition":"the yes/no/unknown indicator to identify use of anticoagulant agents for any patient medical condition.","longName":"ACOAG_ADM_IND-3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014209","version":"1","preferredName":"Anticoagulant Agent Administered","preferredDefinition":"the administration of anticoagulant to the patient.","longName":"ACOAG_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2184079","version":"1","preferredName":"Anticoagulant Agent","preferredDefinition":"A drug that helps prevent blood clots from forming. Also called a blood thinner.","longName":"Anticoagulant Agent","context":"TEST","contextVersion":"1","Concepts":[{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB67BCB3-50E0-6E9A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"BMCCURRY","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B67A9228-B532-053B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-12","endDate":null,"createdBy":"CVALMONT","dateCreated":"2003-02-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO 11179 compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2857180","version":"1","longName":"Type of Category","context":"NIDCR","ClassificationSchemeItems":[{"publicId":"2812095","version":"1","longName":"Adjunctive General Services","context":"NIDCR"}]},{"publicId":"2857182","version":"1","longName":"Protocol Forms","context":"NIDCR","ClassificationSchemeItems":[{"publicId":"2812039","version":"1","longName":"PEARL","context":"NIDCR"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"},{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"}]}],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text1","type":"Alternate Question Text","description":"Is the patient on anticoagulation therapy","url":null,"context":"CTEP"},{"name":"COMMENT_358","type":"COMMENT","description":"Specify the anticoagulant agent according to protocol using the \"Agent Name\" CDE","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Is the patient on anticoagulant therapy","url":null,"context":"CTEP"},{"name":"Has the patient taken anticoa","type":"Preferred Question Text","description":"Has the patient taken anticoagulant agents?","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Is patient receiving systemic treatment anticoagulation","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_3","type":"Alternate Question Text","description":"Is patient receiving therapeutic treatment with indicated anticoagulation agents","url":null,"context":"COG"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Does patient require the use of concomitant antiplatelet agents (except low-dose aspirin) or anticoagulation with warfarin, other vitamin K antagonists, treatment-dose unfractrionated or low molecular weight heparin or other anticoagulants at treatment doses is prohibited, as is treatment with these agents in the 28 days prior to enrollment?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Thromboprophylaxis","url":null,"context":"CTEP"},{"name":"NRG_CRF text","type":"Alternate Question Text","description":"Does the patient require concomitant treatment, in therapeutic doses, with anticoagulants such as warfarin or warfarin-related agents, heparin, thrombin or Factor Xa inhibitors, or antiplatelet agents (e.g. clopidogrel)?","url":null,"context":"NRG"},{"name":"PBTC_Text1, exclusion","type":"Alternate Question Text","description":"Is patient on therapeutic doses of warfarin sodium or any other coumadin-derivative anticoagulant?","url":null,"context":"PBTC"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Patient is currently on anticoagulation therapy?","url":null,"context":"PBTC"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Is patient currently receiving therapeutic anti-coagulation with the indicated agents","url":null,"context":"COG"},{"name":"CRF_Text_4","type":"Alternate Question Text","description":"Is the patient being therapeutically treated with an agent such as warfarin?","url":null,"context":"CTEP"},{"name":"ECOG Text 1","type":"Alternate Question Text","description":"Current anticoagulants use","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Is patient receiving anticoagulation with oral anticoagulants or platelet inhibitors?","url":null,"context":"COG"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Is the patient receiving therapeutic anticoagulation?","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Was it recommended by a doctor or other health care professional?","url":null,"context":"Alliance"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Was anticoagulant agent administered?","url":null,"context":"COG"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Is patient  taking warfarin?","url":null,"context":"PBTC"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is the patient receiving a coumarin-derivative anticoagulant?","url":null,"context":"NRG"},{"name":"NRG_CRF_TEXT 2","type":"Alternate Question Text","description":"Any current or planned therapy with warfarin?","url":null,"context":"NRG"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Concomitant use of heparin or warfarin?","url":null,"context":"Alliance"},{"name":"COG CRF text 6","type":"Alternate Question Text","description":"Did the patient receive any anti-coagulation related to SARS CoV-2 infection?","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Has the patient received anticoagulation with oral anticoagulants (e.g., warfarin, direct thrombin, and Factor Ax inhibitors) or platelet inhibitors (e.g., clopidogrel)?","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Has the patient received anticoagulation with oral coumarin agents (eg warfarin), direct thrombin inhibitors (eg dabigatran), direct factor Xa inhibitor betrixaban, or platelet inhibitors (eg, clopidogrel)?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1BF553C4-8C50-387A-E050-BB89AD4341B6","latestVersionIndicator":"Yes","beginDate":"2015-07-28","endDate":null,"createdBy":"PWEST","dateCreated":"2015-07-28","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":"ISO 11179 compliance. VD was phased out for harmonization - switched to new vd. pjw 7/28/15","administrativeNotes":"2022.8.31 AQT added per ticket request CADSR-TASK0001488. ak 2022.12.2 AQT added for ticket request CADSR0001756. ak","unresolvedIssues":null,"deletedIndicator":"No"}}